EyePoint, Inc. Common Stock (EYPT)
LABORATORY ANALYTICAL INSTRUMENTS
EyePoint, Inc. Common Stock (EYPT) is listed on Nasdaq, where it has traded since January 27, 2005.
- Listed On
- Nasdaq
- Listed Since
- January 27, 2005
- Employees
- 214
- Market Cap
- $33M
About EyePoint, Inc. Common Stock
EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 181 institutions reported holding EYPT, with 92.7 million shares worth $1.3 billion in aggregate. The largest reported holder was Suvretta Capital Management, with 8.3 million shares worth $118.6 million. Of the 5 largest holders listed below, 3 added shares, 1 reduced its position and 1 held its position unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Suvretta Capital Management | 8,296,375 | $119M | Unchanged |
| BlackRock | 7,463,197 | $107M | Added 3.98% |
| Cormorant Asset Management | 7,000,000 | $100M | Reduced 15.31% |
| Federated Hermes | 5,681,052 | $81M | Added 0.2% |
| Vanguard | 5,268,930 | $75M | Added 6.09% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is EYPT?
EyePoint, Inc. Common Stock (EYPT) is listed on Nasdaq, where it has traded since January 27, 2005.
Who are the largest institutional holders of EYPT?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of EYPT were Suvretta Capital Management, BlackRock and Cormorant Asset Management.
How many institutions own EYPT?
181 institutions reported a position in EYPT for the quarter ended June 30, 2026, worth $1.3 billion in total.
Did institutions buy or sell EYPT last quarter?
Of the 5 largest reported holders, 3 added shares, 1 reduced its position and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for EYPT.
Every reported institutional holder, plus insider and congressional trades in EYPT, on SentiSense.